Answers are grounded in this paper and cite their sources.
Experimental study reveals distinct alarmin regulation of airway tone in human lungs, suggesting novel therapeutic targets for asthma.
Alarmins, including Thymic Stromal Lymphopoietin (TSLP) and Interleukins 33 and 25 (IL-33 and IL-25), contribute to the pathophysiology of allergic and nonallergic asthma by evoking exacerbations in response to allergens, viruses, and environmental irritants (as reviewed in [1]). Current evidence shows that inhibiting alarmins reduces symptoms and exacerbations in obstructive lung diseases, including asthma [1]. Preclinical work has largely focused on alarmins' role in modulating airway inflammation, but far less is known about how alarmins regulate airway tone (contraction and relaxation). We posit that IL-33, TSLP, and IL-25 exert distinct effects on airway contraction and relaxation in airways from non-diseased subjects and those with asthma.
No takes yet. Share an insight, caveat, or question.
Kennedy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: